Bridge City Capital’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
Bridge City Capital's IRMD Position: Q3 2026 in Review
Bridge City Capital increased its iRadimed (IRMD) stake by 37% in Q3 2026, buying an estimated $2.33M and bringing the position to 96,975 shares worth $8.36M. The position accounts for 1.74% of the portfolio, ranked #14.
Bridge City Capital first reported a position in IRMD in Q3 2023 and has held it in 13 quarters since. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- Bridge City Capital held 96,975 shares of iRadimed worth $8.36M as of Q3 2026.
- Bridge City Capital bought 25,932 iRadimed shares in Q3 2026, an estimated $2.33M.
- iRadimed made up 1.74% of Bridge City Capital's portfolio in Q3 2026, its #14 holding.
- Bridge City Capital first reported a position in iRadimed in Q3 2023 and has held it in 13 quarters since.
- 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on Bridge City Capital's 13F filing for Q3 2026, filed 29 Oct 2026.